Emergent BioSolutions Q3 EPS $1.21 Beats $0.9 Estimate, Sales $311.8M Beat $289.27M Estimate

Emergent BioSolutions (NYSE:EBS) reported quarterly earnings of $1.21 per share which beat the analyst consensus estimate of $0.9 by 34.44 percent. This is a 120 percent increase over earnings of $0.55 per share from the

Benzinga · 11/06/2019 21:28

Emergent BioSolutions (NYSE:EBS) reported quarterly earnings of $1.21 per share which beat the analyst consensus estimate of $0.9 by 34.44 percent. This is a 120 percent increase over earnings of $0.55 per share from the same period last year. The company reported quarterly sales of $311.8 million which beat the analyst consensus estimate of $289.27 million by 7.79 percent. This is a 79.55 percent increase over sales of $173.653 million the same period last year.